New discovery being dubbed as a 'super antibody'

By Admin
Share
A ‘super antibody which fights against all types of influenza A has been discovered by a team of Swiss and British researchers. The scientists ar...

A ‘super antibody’ which fights against all types of influenza A has been discovered by a team of Swiss and British researchers.

The scientists are now hopeful the finding could lead to the development of an emergency treatment for the virus and revolutionise flu vaccines.

In the current situation, flu vaccine makers have to adapt their jabs every year to make sure they are able to combat the seasonal flu strains.

However, the new development looks like it could act as a universal vaccine which has the ability to fight many types of the flu virus.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

After looking at 100,000 cell samples, the scientists were able to identify an antibody which effectively targeted the haemagglutinin protein which is found on the surface of all influenza A viruses.

Sir John Skehel, a Medical Research Council scientist who worked on the project, said in a media interview: “We've tried every subtype of influenza A and it interacts with them all.

“We eventually hope it can be used as a therapy by injecting the antibody to stop the infection.”

Meanwhile, the director of the Institute for Research in Biomedicine in Switzerland, Antonio Lanzavecchia, stated: “As the first and only antibody which targets all known subtypes of the influenza A virus, FI6 represents an important new treatment option.”

The findings of the experiments have been published in the Science Express journal. 

Share

Featured Articles

How Huawei's Digital Solutions are Transforming Healthcare

Offering network, cloud, and AI solutions, Huawei is able to help healthcare providers deliver better outcomes for patients

2024 Nestlé Nutrition Symposium Explored Food & Health

Nestlé manufactures 4.5m KitKats every day, but the food giant is also focused on advancing food nutrition, as explored at the 2024 International Symposium

Thirona’s AI Tech is Creating Individualised Patient Care

Eva van Rikxoort, CEO and Founder of Thirona, tells us how AI technology is advancing lung imaging and bringing more individualised treatment to patients

AstraZeneca’s Discovery Centre, Constructed by Mace Group

Technology & AI

NeoGenomics: Data in Oncology Testing & Diagnostics

AI & ML

Samsung’s New Health Software Development Kit Suite

Digital Healthcare